Eastman Chemical (EMN) Reports In-Line Q4 EPS; offers guidance
Tweet
Share
E-mail
Get Alerts EMN Hot Sheet
Price: $70.53 -0.93%
EPS Growth %: +71.9%
Financial Fact:
Cost of sales: 1.67B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +71.9%
Financial Fact:
Cost of sales: 1.67B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Eastman Chemical (NYSE: EMN) reported Q4 EPS of $0.75, in-line with the analyst estimate of $0.75. Revenue for the quarter came in at $1.97 billion versus the consensus estimate of $2.03 billion.
GUIDANCE:
Eastman Chemical sees Q1 2026 EPS of $1.00-$1.20, versus the consensus of $1.28.
For earnings history and earnings-related data on Eastman Chemical (EMN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Explosions heard on Iran's Kharg island - MEHR
- BridgeBio Oncology reports new data for KRAS cancer drug BBO-8520
- Block applies for national trust bank charter with OCC
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
